Jürgen Dinger

Publications

Dinger Jürgen, Heinemann Klaas, Moehner Sabine, Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: Results from the extended INAS-SCORE study. Frontiers in Women's Health. 2020; Vol. 5: 1-8. 10.15761/FWH.1000178.
Download PDF: Jürgen-et-al.-2020_Results-from-the-extended-INAS-SCORE-study.pdf

Dinger Jürgen, COCs containing dienogest and 30 μg ethinylestradiol may carry a higher VTE risk compared to corresponding preparations with levonorgestrel: A meta-analysis of four large cohort studies. Frontiers in Women's Health. 2020; Vol. 5: 1-6. 10.15761/FWH.1000175.
Download PDF: Jürgen-2020_COCs-containing-dienogest-and-30-μg-ethinylestradiol.pdf

Barnett Clare, Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study Contraception & Reproductive Health Care. 2019; 1-4. 10.1080/13625187.2019.1629412.

Heinemann Klaas, Dinger Jürgen, Do Minh Thai, Franke Christian, Unintended Pregnancies in Users of Different Combined Oral Contraceptives – Final results from the INAS-SCORE Study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.

Heinemann Klaas, Hagemann Christine, Do Minh Thai, Franke Christian, Dinger Jürgen, Cardiovascular Safety in Users of Different Combined Oral Contraceptives – Final results from the INAS-SCORE Study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.

Barnett Clare, Hagemann Christine, Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study Eur J Contracept Reprod health Care. 2016; Oct 17:1-7. 10.1080/13625187.2016.1241991.

Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Impact of Estrogen Type on Cardiovascular Safety of Combined Oral Contraceptives Contraception. 2016; Oct;94(4):328-39. 10.1016/j.contraception.2016.06.010.

Bardenheuer Kristina, Dinger Jürgen, Franke Christian, Hagemann Christine, Moehner Sabine, Unintended pregnancies in users of different combined oral contraceptives - final results from the INAS-SCORE study. Pharmacoepidemiology and Drug Safety. 2015; 24 (S1): 1–587. 10.1002/pds.3838.

Heinemann Klaas, Dinger Jürgen, Baseline risk factors for cardiovascular events: differences between the USA and Russia in a study population of combined oral contraceptives Pharmacoepidemiology and Drug Safety. 2014; Sep; 23(S1): 1-497. 10.1002/pds.3701.

Dinger Jürgen, Bardenheuer Kristina, Heinemann Klaas, Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception. 2014; Apr; 89(4): 253–63.. 10.1016/j.contraception.2014.01.023.

Dinger Jürgen, Heinemann Klaas, Transatlantic active surveillance of cardiovascular safety (TASC) of an Etonogestrel/Ethinylestradiol-containing vaginal ring. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Venous thromboemolism in users of a 24-day regimen of a combined oral contraceptive compare to conventional 21-day regimens: final results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Dinger Jürgen, Nitschmann S, Kardiovaskuläre Auswirkungen hormoneller Kontrazeption Internist. 2013; 54:1520-1522. doi:10.1007/s00108-013-3394-5.

Rabe T (DGGEF) und Albring C(BVF) zusammen mit dem Arbeitskreis "Thrombophilie und Kontrazeption" , Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Koenig K, Merkle E, Mueck A O, Merki G, Egarter C, Sicherheit hormonaler Kontrazeptiva: Diane 35 und deren Generika.. Frauenarzt 54. 2013; Nr.4.

Heinemann Klaas, Dinger Jürgen, Bardenheuer Kristina, The safety of oral contraceptives in adolescents. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Dinger Jürgen, Heinemann Klaas, Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring. Obstetrics & Gynecology. 2013; 122(4): 800 - 808. 10.1097/AOG.0b013e3182a5ec6b.
Download PDF: Cardiovascular_Risk_Associated_With_the_Use_of_an.11.pdf

Barnett Clare, Heinemann Klaas, Dinger Jürgen, Intrauterine devices and risk of uterine perforations: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S2) 45. DOI 10.1002.

Heinemann Klaas, Assmann Anita, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 365. DOI 10.1002.

Dinger Jürgen, Bardenheuer Kristina, M Kieble, Informationsquellen von seltenen schwerwiegenden Erkrankungen: Arzt oder Patient? . Abstractband der 7. Jahrestagung der Deutschen Gesellschaft für Epidemiologie,. 2012; Sept: 133(P1).

Rabe T, Luxembourg B, Dinger Jürgen, Kontrazeption & Thrombophilie - Eine Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e.V. und des Berufsverbands für Frauenärzte (BVF) e.V. . Journal of Reproductive Medicine and Endocrinology. 2012; Sept:(1):20-63.

Dinger Jürgen, M Kieble, Rare serious adverse events: comparison of patient- and physician-reported outcomes. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 732. DOI 10.1002.

Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Thrombophilie und/oder Z. n. Thromboembolie: Auswahl der richtigen Kontrazeption - Teil 2: Vorgehen bei Risikogruppen. . Gyne Fachzeitschrift für den Arzt der Frau. 2012; Jan;32 Jahrgang.

Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Thrombophilie und/oder Z. n. Thromboembolie: Auswahl der richtigen Kontrazeption - Teil 3: Vorgehen bei Risikogruppen. . Gyne Fachzeitschrift für den Arzt der Frau. 2012; Apr;33 Jahrgang.

Bardenheuer Kristina, Dinger Jürgen, VTE risk in users of combined oral contraceptives: impact of a 24-Day regimen containing drospirenone. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 361. DOI 10.1002.

Barnett Clare, Heinemann Klaas, Dinger Jürgen, Complications associated with unintended pregnancies under IUD use: results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 125.

Dinger Jürgen, EURAS-HRT: cardiovascular and other outcomes - international menopause society. The Journal of Adult Women`s Health & Medicine. 2011; Vol. 14 Supplement 1: 214.

Barnett Clare, Heinemann Klaas, Dinger Jürgen, Intrauterine devices and the risk of uterine perforation: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 233.

Dinger Jürgen, Assmann Anita, Oral contraceptives and the risk of VTE: reanalysis of the EURAS/LASS study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 74.

Heinemann Klaas, Barnett Clare, Dinger Jürgen, Risk factors for uterine perforations during IUD insertion: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 138.

Dinger Jürgen, Bardenheuer Kristina, Franke Christian, The risk of VTE in users of a 24-day regimen of a combined oral contraceptive compared to conventional 21-day OC regimes: results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 131.

Assmann Anita, Heinemann Klaas, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 181.

Dinger Jürgen, Franke Christian, Use of hormonal contraceptives in europe and in the USA: comparative data from the TASC study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 182.

Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Contraception and thrombophilia - a statement from the german society for gynecological endocrinology and reproductive medicine (DGGEF e.V.) and the professional association of german gynaecologists. J Reproduktionsmed Endokrinol. 2011; 8 (Special Issue 1): 126-167.

Dinger Jürgen, Bardenheuer Kristina, Do Minh Thai, Dose of estrogen and contraceptive failure rates of combined oral contraceptives. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 75.

Rabe T, Goeckenjan M, Ahrendt H-J, Crosignani PG, Dinger Jürgen, Mueck A O, Lohr PA, Creinin MD, Sabatini R, Strowitzki T, Oral contraceptive pills: combinations, dosages and the rational behind 50 years of oral hormonal contraceptive development. J Reproduktionsmed Endokrinol. 2011; 8 (Special Issue 1): 33-104.

Bardenheuer Kristina, Dinger Jürgen, Leddin Janko, Reasons for oral contraceptives use in adolescents and adults in europe. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 118.

Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, Safety and effectiveness of oral contraceptives in obese women. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 15.

Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Thrombophilie und/oder Z. n. Thromboembolie: Auswahl der richtigen Kontrazeption - Teil 1: Vorgehen bei Risikogruppen. . Gyne Fachzeitschrift für den Arzt der Frau,. 2011; Dec;32 Jahrgang.

Bardenheuer Kristina, Dinger Jürgen, Franke Christian, Impact of obesity on the safety and effectiveness of oral contraceptives. 56. GMDS-Jahrestagung und 6. DGEpi-Jahrestagung, German Medical Science GMS Publishing House. 2011; Doc11gmds331..

Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Albring C, Risikofaktor Reisethrombose, Umgang mit hormonalen Kontrazeptiva & Indikation zur Thrombophiliediagnostik gyne. Fachzeitschrift für den Arzt der Frau. 2011; 04/2011; 25-29.

Dinger Jürgen, Do Minh Thai, Bardenheuer Kristina, Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstetrics and Gynecology. 2011; 117:33-40.

Dinger Jürgen, Bardenheuer Kristina, Breast cancer risk associated with the use of levonorgestrel-containing intrauterine devices compared to copper intrauterine devices. Eur J Contracept Reprod Health Care. 2010; S1:46-47.

Dinger Jürgen, Do Minh Thai, Early use effects on the risk of venous thromboembolism after initiation of oral contraceptive use. Eur J Contracept Reprod Health Care. 2010; 15;S1:43.

Dinger Jürgen, Assmann Anita, Long-term active surveillance study for oral contraceptives (LASS): Impact of oral contraceptive use on the start of antihypertensive treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S232.

Dinger Jürgen, Assmann Anita, Moehner Sabine, Do Minh Thai, Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care. 2010; 36(3):123-129.

Dinger Jürgen, Assmann Anita, Bardenheuer Kristina, Safety long-term active surveillance study for oral contraceptives (LASS): Results on venous and arterial thromboembolism. Eur J Conctracept Reprod Health Care. 2010; S1:128.

Assmann Anita, Heinemann Klaas, Dinger Jürgen, The safety of oral hormone replacement therapy: Interim results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2010; 19:S31-32.

Dinger Jürgen, Barnett Clare, Moehner Sabine, Assmann Anita, Unintended pregnancies in women using intrauterine devices: Results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2010; 19:S242.

Shapiro Sid, Dinger Jürgen, Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies J Fam Plann Reprod Health Care. 2010; 36:33-38. 10.1783/147118910790291037.

Bardenheuer Kristina, Dinger Jürgen, Franke Christian, Sicherheit und effektivität von oralen kontrazeptiva bei jugendlichen. Gesundheitswesen. 2010; 72:624.

Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Franke Christian, Leddin Janko, Differences in drug utilization of oral contraceptives in the US and Europe. Pharmacoepidemiology and Drug Safety. 2010; 19:S241.

Bardenheuer Kristina, Dinger Jürgen, Assmann Anita, Heinemann Klaas, Leddin Janko, Drug utilization study on the prescribing indications of oral contraceptives in croatia. Pharmacoepidemiology and Drug Safety. 2010; 19:S55.

Bardenheuer Kristina, Barnett Clare, Dinger Jürgen, Franke Christian, Risk profile and OC utilization patterns of women enrolled in INAS-SCORE. Pharmacoepidemiology and Drug Safety. 2010; 19:S30.

Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, Safety and effectiveness of oral contraceptives in adolescents. Eur J Contracept Reprod Health Care. 2010; 15;S1:81.

Dinger Jürgen, Do Minh Thai, The risk of venous thromboembolism in OC users: time patterns after initiation of treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S214-215.

Bardenheuer Kristina, Dinger Jürgen, Assmann Anita, Leddin Janko, Unterschiede in der europäischen und US-amerikanischen Studienpopulation am Beispiel INAS-OC. Gesundheitswesen. 2010; 72:624.

Heinemann Lothar A , Dinger Jürgen, Assmann Anita, Do Minh Thai, Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare" Contraception. 2010; May;81(5):401-7. 10.1016/j.contraception.2009.12.014.

Dinger Jürgen, Bardenheuer Kristina, The risk of vaenous thromboembolism in users of a drospirenone-containing oral contraceptive with a 24-day regimen - results from the INAS-OC study. Fertility and Sterility. 2010; 94 suppl 1:S3.

Cronin Maureen, Schellschmidt Ilka, Dinger Jürgen, Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives Obstet Gynecol. 2009; Sep;114(3):616-22. 10.1097/AOG.0b013e3181b46f54.

Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, International active surveillance study of women taking oral contraceptives (INAS-OC Study) BMC Medical Research Methodology. 2009; 9: 77.. 10.1186/1471-2288-9-77.

Dinger Jürgen, Cronin Maureen, Schellschmidt Ilka, Do Minh Thai, Westhoff C, Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol. 2009; Sep;201(3):263.e1-9. doi: 10.1016/j.ajog.2009.03.017.

Dinger Jürgen, Oral contraceptives and venous thromboembolism: old questions revisited J Fam Plann Reprod Health Care. 2009; 35:211-213. doi: 10.1783/147118909789587385..

Cronin Maureen, Schellschmidt Ilka, Dinger Jürgen, Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives Obstet Gynecol. 2009; 114(3):616-22. 0.1097/AOG.0b013e3181b46f54.

Dinger Jürgen, Assmann Anita, Altmann Matthias, Contraceptive efficacy of oral contraceptives under real life conditions; the impact of a 24-day regimen on contraceptive effectiveness. Pharmacoepidemiol Drug Saf. 2008; 17: S104.

Assmann Anita, Dinger Jürgen, Filonenko A, Do Minh Thai, Heinemann Lothar A , Impact of severe premenstrual disorders on work, daily life, social relations, and quality of life: preliminary results of a multinational follow-up study. Pharmacoepidemiol Drug Saf. 2008; 17: S116.

Dinger Jürgen, Assmann Anita, Kuehl-Habich D, Oral contraceptives and the risk of arrhythmia: final results from the EURAS-OC study. Pharmacoepidemiology and Drug Safety. 2008; 17: S260.

Dinger Jürgen, Assmann Anita, Kolbeck A, Cardiovascular safety of oral hormone replacement: interim results from the EURAS-HRT study. Pharmacoepidemiol Drug Saf. 2008; 17: S270.

Dinger Jürgen, Assmann Anita, The safety of HRT under real life conditions: interim results from the EURAS HRT study. Gynecol Endocrinol. 2008; 24: S51.

Raff T, Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, The risk of uterine and ovarian cancer for different formulations of hormone therapy (HT). The Open Epidemiology Journal. 2008; 1:17-25.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.

Heinemann Lothar A , Dinger Jürgen, Range of published estimates of VTE incidence in young women Contraception. 2007; 75: 3328-336.

Dinger Jürgen, Heinemann Lothar A , Kuehl-Habich D, The safety of a drospirenone-containing oral contraceptive: Final results from the European Active Surveillance study on Oral Contraceptives (EURAS-OC) based on 142,475 women-years of observation Contraception. 2007; DOI: 10.1016/j.contraception.2006.12.019.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.

Dinger Jürgen, Heinemann Lothar A , Westhoff C, Final results from the EURAS study: impact of oral contraception on public health. Obstet Gynecol. 2007; 109(4): 5S.

Dinger Jürgen, Heinemann Lothar A , Westhoff C, First results from the international active surveillance study on oral contraceptives (INAS-OC). Obstet Gynecol. 2007; 109(4): 58S.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The safety and efficacy of oral contraceptives in teenagers: results from the EURAS-OC study. Pharmacoepidemiology and Drug Safety. 2007; 16: S13.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Interim results from the international active surveillance study of women taking oral contraceptives (INAS OC). Pharmacoepidemiology and Drug Safety. 2007; 16: S211.

Dinger Jürgen, Assmann Anita, Kuehl-Habich D, The safety of oral hormone replacement therapy under real life conditions: interim results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2007; 16: S213.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Design issues in active surveillance studies: experience from the EURAS studies.. Pharmacoepidemiology and Drug Safety. 2007; 16: S253.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.

Heinemann Lothar A , Moore C, Dinger Jürgen, Stoehr D, Sensitivity as outcome measure of androgen replacement: the AMS scale. Health and Quality of Life Outcomes. 2006; 4:23.

Dinger Jürgen, Zimmermann T, Heinemann Lothar A , Stoehr D, Quality of life and hormone use: new validation results of MRS scale. Health and Quality of Life Outcomes. 2006; 4:32.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.

Dinger Jürgen, Heinemann Lothar A , European Active Surveillance Study of Women taking HRT (EURAS-HRT): study protocol BMC Women's Health. 2006; 6:1. DOI: 10.1186/1472-6874-6-1.

Heinemann Lothar A , Dinger Jürgen, Klinische Studien – eine Evidenzfalle?. Frauenarzt. 2006; 47:331-35.l.

Heinemann Lothar A , Assmann Anita, Dinger Jürgen, The risk of venous thromboembolism (VTE) in oral contraceptives: a new lesson. Pharmacoepidemiology and Drug Safety. 2006; 15: S24.

Schellschmidt I, Do Minh Thai, Dinger Jürgen, Factors influencing return to fertility after use of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S25.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The European active surveillance study on oral contraceptives (EURAS-OC): final results after more than 130,000 WY of observatio. Pharmacoepidemiology and Drug Safety. 2006; 15: S26.

Assmann Anita, Dinger Jürgen, Heinemann Lothar A , European active surveillance of women taking HRT (EURAS-HRT). Pharmacoepidemiology and Drug Safety. 2006; 15: S73.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , International active surveillance study of women taking oral contraceptives (INAS-OC). Pharmacoepidemiology and Drug Safety. 2006; 15: S132.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The impact of obesity on the contraceptive reliability of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S140.

Heinemann Lothar A , Dinger Jürgen, The menopause rating scale (MRS) as outcome measure for hormone treatment. Pharmacoepidemiology and Drug Safety. 2006; 14: S44.

Heinemann Lothar A , Dinger Jürgen, Safety of a new oral contraceptive containing drospirenone Drug Safety. 2004; 27(13):1001-18.